Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 18.

Studt, J D; Alberio, L; Angelillo-Scherrer, A; Asmis, L M; Fontana, P; Korte, W; Mendez, A; Schmid, P; Stricker, H; Tsakiris, D A; Wuillemin, W A; Nagler, Michael (2017). Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels. Journal of Thrombosis and Haemostasis, 15(8):1576-1583.

Bulla, O; Poncet, A; Albeiro, L; Asmis, L M; Gähler, A; Graf, L; Nagler, M; Studt, J D; Tsakiris, D A; Fontana, P (2017). Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study. Haemophilia, 23(4):e335-e339.

Asmis, L M; Alberio, L; Angelillo-Scherrer, A; Korte, W; Mendez, A; Reber, G; Seifert, Burkhardt; Stricker, H; Tsakiris, D A; Wuillemin, W A (2012). Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests A study in 9 Swiss laboratories. Thrombosis Research, 129(4):492-498.

Valsami, S; Ruf, W; Leikauf, M S; Madon, J; Kaech, A; Asmis, L M (2011). Immunomodulatory drugs increase endothelial tissue factor expression in vitro. Thrombosis Research, 127(3):264-271.

Theusinger, O M; Baulig, W; Seifert, Burkhardt; Emmert, M Y; Spahn, D R; Asmis, L M (2011). Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma. British Journal of Anaesthesia, 106(4):505-511.

Theusinger, O M; Baulig, W; Asmis, L M; Seifert, B; Spahn, D R (2010). In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM®). Thrombosis and Haemostasis, 104(2):385-391.

Nielsen, V G; Asmis, L M (2010). Hypercoagulability in the perioperative period. Best Practice & Research: Clinical Anaesthesiology, 24(1):133-144.

Theusinger, O M; Nürnberg, J; Asmis, L M; Seifert, B; Spahn, D R (2010). Rotation thromboelastometry (ROTEM®) stability and reproducibility over time. European Journal of Cardio-Thoracic Surgery, 37(3):677-683.

Bosshart, M; Stover, J F; Stocker, R; Asmis, L M; Feige, J; Neff, T A; Schuepbach, R A; Cottini, S R; Béchir, M (2010). Two different hematocrit detection methods: Different methods, different results? BMC Research Notes, 3:65.

Schicker, B; Kuhn, M; Fehr, R; Asmis, L M; Karagiannidis, C; Reinhart, W H (2009). Particulate matter inhalation during hay storing activity induces systemic inflammation and platelet aggregation. European Journal of Applied Physiology, 105(5):771-778.

Spahn, D R; Asmis, L M (2009). Excessive perioperative bleeding: are fibrin monomers and factor XIII the missing link? Anesthesiology, 110(2):212-213.

Dindo, D; Breitenstein, S; Hahnloser, D; Seifert, Burkhardt; Yakarisik, S; Asmis, L M; Muller, M K; Clavien, P A (2009). Kinetics of D-dimer after general surgery. Blood Coagulation and Fibrinolysis, 20(5):347-352.

Asmis, L M; Segal, J B; Plantinga, L C; Fink, E N; Kerman, J S; Kickler, T S; Coresh, J; Gardner, L B (2008). Heparin-induced antibodies and cardiovascular risk in patients on dialysis. Thrombosis and Haemostasis, 100(3):498-504.

Krafft, A; Asmis, L M; Zimmermann, R (2008). Treatment of midgestational placental haemorrhage with recombinant factor VIIa. Thrombosis and Haemostasis, 100(1):154-155.

Asmis, L M; Asmis, R; Sulzer, I; Furlan, M; Lämmle, B (2008). Contact system activation in human sepsis - 47 kD HK, a marker of sepsis severity? Swiss Medical Weekly, 138(9-10):142-149.

Stämpfli, S F; Asmis, L M; Tanner, F C (2008). Wirkungsweise alter und neuer Antikoagulanzien. Herz, 33:4-12.

Asmis, L M (2007). Niedermolekulare Heparine (NMH): Eine effektive Therapie bei sorgfältiger Indikationsstellung. Cardiovasc:16-22.

Schmidt, D; Asmis, L M; Odermatt, B; Kelm, J; Breymann, C; Gössi, M; Genoni, M; Zund, G; Hoerstrup, S P (2006). Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors. Annals of Thoracic Surgery, 82(4):1465-1471.

This list was generated on Sun Jun 16 21:32:06 2019 CEST.